|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 8.330 USD | +6.11% |
|
+20.03% | +165.29% |
| 09-18 | Chardan Initiates Agenus at Buy With $40 Price Target | MT |
| 09-11 | Agenus Inc. - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGENUS INC. | Other Biotechnology & Medical Research | +6.11% | +20.03% | +165.29% | +90.18% | -92.84% | 353M |  |  | |
- Stock Market
- Stocks
- AGEN Stock
- Charts Agenus Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
